Literature DB >> 29598788

Gene silencing of heparanase results in suppression of invasion and migration of gallbladder carcinoma cells.

Hao Jin1, Min Cui1.   

Abstract

This study investigated the effect of transcriptional gene silencing of the heparanase gene on standard gallbladder carcinoma cells (GBC-SD). The miRNAs targeting the promoter region and coding region of the heparanase gene were designed and synthesized. We transfected four recombinant miRNA vectors into GBC-SD. We performed the wound healing assays and invasion assays. The result shows that the heparanase expression was significantly decreased by recombinant vectors in transfected GBC-SD cells (p < 0.01), of which pmiR-Hpa-2 showed best interference effect (p < 0.05). The penetrated and migrating cells numbers and adherence rate of GBC-SD cells were significantly decreased by pmiR-Hpa-2 (p < 0.05).

Entities:  

Keywords:  Gallbladder carcinoma; RNA interference; heparanase; tumor invasion and metastasis

Mesh:

Substances:

Year:  2018        PMID: 29598788     DOI: 10.1080/09168451.2018.1456316

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  3 in total

1.  Recognition of potential therapeutic role of 2-hydroxy-3-methylanthraquinones in the treatment of gallbladder carcinoma: A proteomics analysis.

Authors:  Hao Jin; Min Cui
Journal:  Fundam Clin Pharmacol       Date:  2021-12-10       Impact factor: 2.748

2.  MAP kinase and mammalian target of rapamycin are main pathways of gallbladder carcinogenesis: results from bioinformatic analysis of next generation sequencing data from a hospital-based cohort (NCT05404347).

Authors:  Monika Rajput; Satyavjiay Chigurupati; Roli Purwar; Mridula Shukla; Manoj Pandey
Journal:  Mol Biol Rep       Date:  2022-08-26       Impact factor: 2.742

3.  [Heparanase promotes trans-endothelial migration of hepatocarcinoma cells by inducing apoptosis of microvascular endothelial cells].

Authors:  Xiaopeng Chen; Rui Ye; Dafei Dai; Yuhai Wu; Yuanlin Yu; Bin Cheng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.